(Q44612866)

4 December 2017

title

Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans (English)

1 reference

4 December 2017

Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-β (Aβ) 40 or Aβ 42 in humans (English)

1 reference

https://api.crossref.org/works/10.1016/S0304-3940(03)00895-4

20 March 2024

4

Fuyuki Miya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550919

20 March 2024

author name string

Kazuhiro Ishii

1

1 reference

4 December 2017

Takahiko Tokuda

2

1 reference

4 December 2017

Teruhiko Matsushima

3

1 reference

4 December 2017

Shin'ichi Shoji

5

1 reference

4 December 2017

Shu-ichi Ikeda

6

1 reference

4 December 2017

Akira Tamaoka

7

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

30 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14550919

full work available at URL

20 March 2024

https://api.elsevier.com/content/article/PII:S0304394003008954?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0304-3940(03)00895-4

https://api.elsevier.com/content/article/PII:S0304394003008954?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0304-3940(03)00895-4

20 March 2024

1 reference

4 December 2017

volume

350

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

161-164

1 reference

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900895-4

7 January 2021

Identifiers

1 reference

4 December 2017

1 reference